Reuters - MUMBAI, Dec 28 (Reuters) - Indian drug maker Ranbaxy Laboratories Ltd (RANB.BO: Quote , Profile , Research ) has received tentative approval from the U.S. Food and Drug Administration for galantamine hydrobromide oral solution, the regulator's Web ...